Free online reference management for clinicians and scientists

Sign up now

Recent "Cytotoxic" articles

  • These articles and links have been posted by Connotea users using the tag "Cytotoxic".
  • To add to this collection, or to start your own library:

Learn more

Watch a short video (2m 41s)

EXPORT LIST RSS ?
Bookmarks matching tag Cytotoxic
Create a Connotea Community Page about this tag. ?
 
Number of articles per page:
10 | 25 | 50 | 100
 
Fludarabine in vitro
www.nature.com
Posted by dam1003 to Etoposide Doxorubicin Cytotoxic fludarabine on Mon Sep 15 2008 at 15:52 UTC | info | related
 
Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Junji Tanaka et al.
Experimental hematology 35 (10), 1562-6 (Oct 2007)
info:pmid/17681668 | info:doi/10.1016/j.exphem.2007.06.006
Posted by nanog to clinical-grade expansion cell product Cytotoxic NK on Fri Nov 09 2007 at 05:04 UTC | info | related
 
mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA - Cytotherapy
www.informaworld.com
Posted by nanog to cancer vaccine dc Cytotoxic on Sun Sep 16 2007 at 01:58 UTC | info | related
 
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
Ida Rasmusson et al.
Journal of Leukocyte Biology, 0307140 (03 Jul 2007)
info:doi/10.1189/jlb.0307140
Posted by nanog to Cytotoxic immunogenecy MSC on Fri Jul 06 2007 at 01:26 UTC | info | related
 
The concurrent chemoradiation paradigm[mdash]general principles
Tanguy Seiwert, Joseph Salama, and Everett Vokes
Nat Clin Prac Oncol 4 (2), 86-100 (Feb 2007)
info:doi/10.1038/ncponc0714
Posted by NatureClinicalPractice to Radiotherapy Chemotherapy synergistic resistance radiation Cytotoxic chemoradiation on Thu Feb 08 2007 at 13:16 UTC | info | related
 
Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial
K E Ugen et al.
Vaccine. 15 (8), 927-30 (Jun 1997)
info:pmid/9234550
0264-410X (Print) Journal Article
Posted by pvs77 to vaccines vaccination Cytotoxic T-Lymphocytes P.H.S. U.S.Gov't Research Support Pan troglodytes Molecular Sequence Data HIV-1 therapy prevention & control HIV Infections BIOSYNTHESIS HIV Antibodies Preclinical Drug Evaluation animal Disease Models viral DNA animals Amino Acid Sequence therapeutic use immunology AIDS Vaccines HIVtrialRef on Thu Nov 09 2006 at 20:19 UTC | info | related
 
HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipients
M J McElrath et al.
AIDS research and human retroviruses. 10 (5), 541-9 (May 1994)
info:pmid/7917516
0889-2229 (Print) Clinical Trial Journal Article
Posted by pvs77 to Time Factors Cytotoxic T-Lymphocytes P.H.S. U.S.Gov't Research Support microbiology macrophages In Vitro humans HIV-1 HIV Seropositivity HIV Seronegativity env Gene Products Pharmacology immunology AIDS Vaccines HIVtrialRef on Thu Nov 09 2006 at 20:19 UTC | info | related
 
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting
M J McElrath et al.
The Journal of infectious diseases. 169 (1), 41-7 (Jan 1994)
info:pmid/8277196
0022-1899 (Print) Clinical Trial Clinical Trial, Phase I Journal Article
Posted by pvs77 to vaccinia virus Synthetic vaccines Cytotoxic T-Lymphocytes P.H.S. U.S.Gov't Research Support Protein Precursors Male Lymphocyte Activation Immunoenzyme Techniques secondary immunization humans HIV-1 prevention & control HIV Infections HIV Envelope Protein gp160 HIV Antibodies env Gene Products Follow-Up Studies Western blotting genetics Baculoviridae BIOSYNTHESIS CD8 Antigens immunology AIDS Vaccines HIVtrialRef on Thu Nov 09 2006 at 20:19 UTC | info | related
 
Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160
B Fleury et al.
The Journal of infectious diseases. 174 (4), 734-8 (Oct 1996)
info:pmid/8843210
0022-1899 (Print) Clinical Trial Journal Article Randomized Controlled Trial
Posted by pvs77 to Synthetic vaccines Cytotoxic T-Lymphocytes Non-U.S.Gov't Research Support Male immunologic memory secondary immunization humans Histocompatibility Antigens Class I HIV-1 HIV Seronegativity HIV Envelope Protein gp160 female genetics Avipoxvirus CD8 analysis CD3 Antigens immunology AIDS Vaccines HIVtrialRef on Thu Nov 09 2006 at 20:19 UTC | info | related
 
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy
G Ferrari et al.
Blood. 90 (6), 2406-16 (15 Sep 1997)
info:pmid/9310492
0006-4971 (Print) Clinical Trial Journal Article
Posted by pvs77 to Viral Vaccines Cytotoxic T-Lymphocytes P.H.S. U.S.Gov't Research Support drug effects Lymphocyte Activation methods immunotherapy Immunophenotyping humans HIV-1 therapy HIV Infections HIV Antigens Genetic Vectors Defective Viruses Pharmacology cytokines immunology Avipoxvirus adult HIVtrialRef on Thu Nov 09 2006 at 20:19 UTC | info | related

<< Prev 0      Showing entries 1 to 10 of 56 total      Next 10 >>